Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 56,352 | 53,919 | 99,067 | 71,079 | 62,629 |
| Cost of Goods | 9,371 | 9,317 | 7,985 | 10,359 | 9,048 |
| Gross Profit | 46,981 | 44,602 | 91,082 | 60,720 | 53,581 |
| Operating Expenses | 61,800 | 70,699 | 82,219 | 79,615 | 64,910 |
| Operating Income | -14,448 | -25,780 | 9,848 | -18,536 | -11,281 |
| Interest Expense | 3,052 | 4,448 | 4,443 | 3,820 | 3,499 |
| Other Income | 615 | -7,196 | -15,492 | -8,321 | 579 |
| Pre-tax Income | -16,885 | -37,424 | -10,087 | -30,677 | -14,201 |
| Net Income Continuous | -16,885 | -37,424 | -10,087 | -30,694 | -14,201 |
| Net Income | $-16,885 | $-37,424 | $-10,087 | $-30,694 | $-14,201 |
| EPS Basic Total Ops | -0.44 | -0.97 | -0.26 | -0.80 | -0.37 |
| EPS Basic Continuous Ops | -0.43 | -0.97 | -0.26 | -0.80 | -0.37 |
| EPS Diluted Total Ops | -0.44 | -0.97 | -0.26 | -0.80 | -0.37 |
| EPS Diluted Continuous Ops | -0.43 | -0.97 | -0.26 | -0.80 | -0.37 |
| EBITDA(a) | $-12,505 | $-23,680 | $11,983 | $-16,431 | $-9,226 |